BIA Membership directory
We represent over 500 companies. Our members include start-up, emerging and more established bioscience companies, pharmaceutical companies, academic, research and philanthropic organisations, and service providers to the life science sector.
You can search by company name or location (click on the tabs above to switch between the two), or use the filters on the right to narrow down your results.
Please note that several of our member companies have sites in multiple locations and so are listed multiple times in the directory. Use the locations tab to view the different sites on the map.
Influence, connect and save with the BIA. Find out about how we can work together.
3PM is a project, programme and portfolio management company that manages the life cycle of projects of varied complexities, across all stages and throughout many sectors. 3PM’s partners have extensive experience in the commercial and science sectors of the property industry, which makes them best placed to undertake this research.
4BIO Capital is a London-based venture capital firm focused solely on the advanced therapies sector.
AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow.
Abingworth is an international investment group dedicated exclusively to the life sciences and healthcare sectors. We invest across all stages of company development including early and late-stage venture financing, growth equity and public companies.
Abzena enables the development of better treatments for patients, through its work with the top biopharmaceutical companies and academic groups worldwide.
With its platform technology, Trocept, Accession Therapeutics is focused on treating some of the most intractable and widespread forms of cancer
Achilles Therapeutics is a biopharmaceutical company developing personalised T cell therapies targeting neoantigens
ACROBiosystems is a leading manufacturer of recombinant proteins and other critical reagents to support the development of target therapeutics, vaccines, and diagnostics
Actimed is leading the way in developing innovative therapies for the unmet medical need of cachexia, ALS and muscle wasting disorders.